CellMed AG, a subsidiary of BTG plc.

Quick facts

Phase 1 pipeline

• CM3.1-AC100

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• CellMed AG, a subsidiary of BTG plc. portfolio CI brief
• CellMed AG, a subsidiary of BTG plc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies